Iowa House Bill HF950

Iowa 2025-2026 Regular Session

• Introduced: 3/12/25
• Refer: 4/3/25

Caption

A bill for an act relating to hemp products and the definition, possession, and allowable forms of medical cannabidiol.(Formerly HF 105.)

Impact

HF950 introduces specific age restrictions, prohibiting the dispensing of inhalable forms of medical cannabidiol to patients under 21 years old, which adds a layer of protection for younger individuals. Additionally, the bill stipulates that patients and primary caregivers must not possess more tetrahydrocannabinol than authorized over a defined 90-day period, reinforcing compliance with medical regulations and ensuring that the distribution of these products remains within limits established by the medical cannabidiol board.

Summary

House File 950 aims to amend regulations surrounding medical cannabidiol in Iowa, particularly enhancing the definitions, possession limits, and forms in which it can be obtained and used. Notably, this bill expands the definition of medical cannabidiol to include inhalable forms such as flowers of the Cannabis sativa L. and Cannabis indica plants. This change recognizes and legalizes the use of more traditional forms of cannabis in medical contexts, which may influence patients seeking alternative therapies.

Contention

While the bill's supporters advocate for a broader acceptance of medical cannabis and its various forms, potential points of contention may arise surrounding the implications of legalizing inhalable products. Concerns may be voiced about the effects of widespread cannabis availability, particularly in relation to youth use and public health. Moreover, the increased regulatory burden on dispensaries to comply with new packaging requirements and age restrictions presents a challenge for businesses operating within the burgeoning hemp industry in Iowa.